Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maximal Androgen Deprivation and Conformal Radiotherapy in Localized Prostate Cancer
NCT00003124Phase 2Completed
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- May 1997
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide, flutamide in prostate cancer (PCa), sponsored by Herbert Irving Comprehensive Cancer Center. Started May 1997; status: completed.
02
Drugs
leuprolideflutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003124.